Activity of secretory sphingomyelinase is increased in plasma of alcohol-dependent patients

Alcoholism: Clinical and Experimental Research

Volumn 35, Issue 10, 2011, Pages 1852-1859

  Reichel, Martin ^a   Beck, Johannes ^a   Mühle, Christiane ^a   Rotter, Andrea ^a   Bleich, Stefan ^a,b   Gulbins, Erich ^c   Kornhuber, Johannes ^a  

^a UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^b HANNOVER MEDICAL SCHOOL   (Germany)

^c UNIVERSITY OF DUISBURG ESSEN   (Germany)

Author keywords

Acid sphingomyelinase; Alcohol induced disorders; Alcoholism; Atherosclerosis; Biological markers; Ceramide; Sphingolipids; Sphingomyelin phosphodiesterase

Indexed keywords

ALCOHOL; CARBOHYDRATE DEFICIENT TRANSFERRIN; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; SPHINGOMYELIN PHOSPHODIESTERASE; TRIACYLGLYCEROL;

ADULT; ALCOHOL WITHDRAWAL; ALCOHOLISM; ARTICLE; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; FEMALE; HUMAN; MALE; PRIORITY JOURNAL;

ADULT; ALCOHOL DRINKING; ALCOHOLICS; ALCOHOLISM; COMORBIDITY; ENZYME ASSAYS; ETHANOL; FEMALE; GASTROINTESTINAL DISEASES; HUMANS; LIVER DISEASES; MALE; MIDDLE AGED; SPHINGOMYELIN PHOSPHODIESTERASE; STUDENTS; TRANSFERRIN; UNIVERSITIES; YOUNG ADULT;

EID: 80053231511     PISSN: 01456008     EISSN: 15300277     Source Type: Journal    
DOI: 10.1111/j.1530-0277.2011.01529.x     Document Type: Article

References (51)

1. Akobeng AK (2007) Understanding diagnostic tests 3: receiver operating characteristic curves. Acta Paediatr 96:644-647.
2. Bolin DJ, Jonas A (1996) Sphingomyelin inhibits the lecithin-cholesterol acyltransferase reaction with reconstituted high density lipoproteins by decreasing enzyme binding. J Biol Chem 271:19152-19158.
3. Brady RO, Kanfer JN, Mock MB, Fredrickson DS (1966) The metabolism of sphingomyelin, II. Evidence of an enzymatic deficiency in Niemann-Pick disease. Proc Natl Acad Sci USA 55:366-369.
4. Carlsson S, Hammar N, Efendic S, Persson PG, Ostenson CG, Grill V (2000) Alcohol consumption, type 2 diabetes mellitus and impaired glucose tolerance in middle-aged Swedish men. Diabet Med 17:776-781.
5. Castillo SS, Levy M, Thaikoottathil JV, Goldkorn T (2007) Reactive nitrogen and oxygen species activate different sphingomyelinases to induce apoptosis in airway epithelial cells. Exp Cell Res 313:2680-2686.
6. Claus RA, Bunck AC, Bockmeyer CL, Brunkhorst FM, Lösche W, Kinscherf R, Deigner HP (2005) Role of increased sphingomyelinase activity in apoptosis and organ failure of patients with severe sepsis. FASEB J 19:1719-1721.
7. Deaciuc IV, Nikolova-Karakashian M, Fortunato F, Lee EY, Hill DB, McClain CJ (2000) Apoptosis and dysregulated ceramide metabolism in a murine model of alcohol-enhanced lipopolysaccharide hepatotoxicity. Alcohol Clin Exp Res 24:1557-1565.
8. Doehner W, Bunck AC, Rauchhaus M, von Haehling S, Brunkhorst FM, Cicoira M, Tschope C, Ponikowski P, Claus RA, Anker SD (2007) Secretory sphingomyelinase is upregulated in chronic heart failure: a second messenger system of immune activation relates to body composition, muscular functional capacity, and peripheral blood flow. Eur Heart J 28:821-828.
9. Duane P, Peters TJ (1988) Nutritional status in alcoholics with and without chronic skeletal muscle myopathy. Alcohol Alcohol 23:271-277.
10. Fernandez-Solà J, Preedy VR, Lang CH, Gonzalez-Reimers E, Arno M, Lin JC, Wiseman H, Zhou S, Emery PW, Nakahara T, Hashimoto K, Hirano M, Santolaria-Fernández F, González-Hernández T, Fatjó F, Sacanella E, Estruch R, Nicolás JM, Urbano-Márquez A (2007) Molecular and cellular events in alcohol-induced muscle disease. Alcohol Clin Exp Res 31:1953-1962.
11. García-Ruiz C, Colell A, Marí M, Morales A, Calvo M, Enrich C, Fernández-Checa JC (2003) Defective TNF-α-mediated hepatocellular apoptosis and liver damage in acidic sphingomyelinase knockout mice. J Clin Invest 111:197-208.
12. Göggel R, Winoto-Morbach S, Vielhaber G, Imai Y, Lindner K, Brade L, Brade H, Ehlers S, Slutsky AS, Schütze S, Gulbins E, Uhlig S (2004) PAF-mediated pulmonary edema: a new role for acid sphingomyelinase and ceramide. Nat Med 10:155-160.
13. González-Quintela A, Dominguez-Santalla MJ, Pérez LF, Vidal C, Lojo S, Barrio E (2000) Influence of acute alcohol intake and alcohol withdrawal on circulating levels of IL-6, IL-8, IL-10 and IL-12. Cytokine 12:1437-1440.
14. 2+-dependent sphingomyelinase activity in the serum of patients with type 2 diabetes is elevated. Horm Metab Res 35:506-507.
15. Grassmé H, Jekle A, Riehle A, Schwarz H, Berger J, Sandhoff K, Kolesnick R, Gulbins E (2001) CD95 signaling via ceramide-rich membrane rafts. J Biol Chem 276:20589-20596.
16. Hannun YA, Obeid LM (2008) Principles of bioactive lipid signalling: lessons from sphingolipids. Nat Rev Mol Cell Biol 9:139-150.
17. Hofmeister R, Wiegmann K, Korherr C, Bernardo K, Krönke M, Falk W (1997) Activation of acid sphingomyelinase by interleukin-1 (IL-1) requires the IL-1 receptor accessory protein. J Biol Chem 272:27730-27736.
18. Hultberg B, Isaksson A, Berglund M, Alling C (1995) Increases and time-course variations in β-hexosaminidase isoenzyme B and carbohydrate-deficient transferrin in serum from alcoholics are similar. Alcohol Clin Exp Res 19:452-456.
19. Hurwitz R, Ferlinz K, Vielhaber G, Moczall H, Sandhoff K (1994) Processing of human acid sphingomyelinase in normal and I-cell fibroblasts. J Biol Chem 269:5440-5445.
20. Jenkins RW, Canals D, Hannun YA (2009) Roles and regulation of secretory and lysosomal acid sphingomyelinase. Cell Signal 21(6):836-846.
21. Jenkins RW, Idkowiak-Baldys J, Simbari F, Canals D, Roddy P, Riner CD, Clarke CJ, Hannun YA (2011) A novel mechanism of lysosomal acid sphingomyelinase maturation: requirement for carboxy-terminal proteolytic processing. J Biol Chem 286(5):3777-3788.
22. Kärkkäinen P, Poikolainen K, Salaspuro M (1990) Serum β-hexosaminidase as a marker of heavy drinking. Alcohol Clin Exp Res 14:187-190.
23. Kolesnick RN (1987) 1, 2-Diacylglycerols but not phorbol esters stimulate sphingomyelin hydrolysis in GH3 pituitary cells. J Biol Chem 262:16759-16762.
24. Kornhuber J, Tripal P, Reichel M, Mühle C, Rhein C, Muehlbacher M, Groemer TW, Gulbins E (2010) Functional Inhibitors of Acid Sphingomyelinase (FIASMAs): a novel pharmacological group of drugs with broad clinical applications. Cell Physiol Biochem 26:9-20.
25. Lee CY, Krimbou L, Vincent J, Bernard C, Larramee P, Genest J Jr, Marcil M (2003) Compound heterozygosity at the sphingomyelin phosphodiesterase-1 (SMPD1) gene is associated with low HDL cholesterol. Hum Genet 112:552-562.
26. Lee CY, Lesimple A, Denis M, Vincent J, Larsen A, Mamer O, Krimbou L, Genest J, Marcil M (2006) Increased sphingomyelin content impairs HDL biogenesis and maturation in human Niemann-Pick disease type B. J Lipid Res 47:622-632.
27. Liu JJ, Wang JY, Hertervig E, Cheng Y, Nilsson A, Duan RD (2000) Activation of neutral sphingomyelinase participates in ethanol-induced apoptosis in Hep G2 cells. Alcohol Alcohol 35:569-573.
28. Loidl A, Claus R, Deigner HP, Hermetter A (2002) High-precision fluorescence assay for sphingomyelinase activity of isolated enzymes and cell lysates. J Lipid Res 43:815-823.
29. Marathe S, Schissel SL, Yellin MJ, Beatini N, Mintzer R, Williams KJ, Tabas I (1998) Human vascular endothelial cells are a rich and regulatable source of secretory sphingomyelinase. Implications for early atherogenesis and ceramide-mediated cell signaling. J Biol Chem 273:4081-4088.
30. Marmillot P, Munoz J, Patel S, Garige M, Rosse RB, Lakshman MR (2007) Long-term ethanol consumption impairs reverse cholesterol transport function of high-density lipoproteins by depleting high-density lipoprotein sphingomyelin both in rats and in humans. Metabolism 56:947-953.
31. McGovern MM, Pohl-Worgall T, Deckelbaum RJ, Simpson W, Mendelson D, Desnick RJ, Schuchman EH, Wasserstein MP (2004) Lipid abnormalities in children with types A and B Niemann Pick disease. J Pediatr 145:77-81.
32. Moss M, Parsons PE, Steinberg KP, Hudson LD, Guidot DM, Burnham EL, Eaton S, Cotsonis GA (2003) Chronic alcohol abuse is associated with an increased incidence of acute respiratory distress syndrome and severity of multiple organ dysfunction in patients with septic shock. Crit Care Med 31:869-877.
33. Pascual M, Valles SL, Renau-Piqueras J, Guerri C (2003) Ceramide pathways modulate ethanol-induced cell death in astrocytes. J Neurochem 87:1535-1545.
34. Reichel M, Greiner E, Richter-Schmidinger T, Yedibela O, Tripal P, Jacobi A, Bleich S, Gulbins E, Kornhuber J (2010) Increased acid sphingomyelinase activity in peripheral blood cells of acutely intoxicated patients with alcohol dependence. Alcohol Clin Exp Res 34:46-50.
35. Romiti E, Vasta V, Meacci E, Farnararo M, Linke T, Ferlinz K, Sandhoff K, Bruni P (2000) Characterization of sphingomyelinase activity released by thrombin-stimulated platelets. Mol Cell Biochem 205:75-81.
36. Santana P, Peña LA, Haimovitz-Friedman A, Martin S, Green D, McLoughlin M, Cordon-Cardo C, Schuchman EH, Fuks Z, Kolesnick R (1996) Acid sphingomyelinase-deficient human lymphoblasts and mice are defective in radiation-induced apoptosis. Cell 86:189-199.
37. Schissel SL, Jiang X, Tweedie-Hardman J, Jeong T, Camejo EH, Najib J, Rapp JH, Williams KJ, Tabas I (1998a) Secretory sphingomyelinase, a product of the acid sphingomyelinase gene, can hydrolyze atherogenic lipoproteins at neutral pH. Implications for atherosclerotic lesion development. J Biol Chem 273:2738-2746.
38. Schissel SL, Keesler GA, Schuchman EH, Williams KJ, Tabas I (1998b) The cellular trafficking and zinc dependence of secretory and lysosomal sphingomyelinase, two products of the acid sphingomyelinase gene. J Biol Chem 273:18250-18259.
39. 2+-stimulated sphingomyelinase is secreted by many cell types and is a product of the acid sphingomyelinase gene. J Biol Chem 271:18431-18436.
40. Schütze S, Potthoff K, Machleidt T, Berkovic D, Wiegmann K, Krönke M (1992) TNF activates NF-kappa B by phosphatidylcholine-specific phospholipase C-induced "acidic" sphingomyelin breakdown. Cell 71:765-776.
41. Smith EL, Schuchman EH (2008) The unexpected role of acid sphingomyelinase in cell death and the pathophysiology of common diseases. FASEB J 22:3419-3431.
42. Stejskal D, Ruzicka V, Fanfrdlova G, Kolar V, Bartek J (2005) High adiponectin and TNF-alpha levels in moderate drinkers suffering from liver steatosis: comparison with non drinkers suffering from similar hepatopathy. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 149:93-99.
43. Subbaiah PV, Liu M (1993) Role of sphingomyelin in the regulation of cholesterol esterification in the plasma lipoproteins. Inhibition of lecithin-cholesterol acyltransferase reaction. J Biol Chem 268:20156-20163.
44. Takahashi T, Abe T, Sato T, Miura K, Takahashi I, Yano M, Watanabe A, Imashuku S, Takada G (2002) Elevated sphingomyelinase and hypercytokinemia in hemophagocytic lymphohistiocytosis. J Pediatr Hematol Oncol 24:401-404.
45. Tam C, Idone V, Devlin C, Fernandes MC, Flannery A, He X, Schuchman E, Tabas I, Andrews NW (2010) Exocytosis of acid sphingomyelinase by wounded cells promotes endocytosis and plasma membrane repair. J Cell Biol 189:1027-1038.
46. Teichgräber V, Ulrich M, Endlich N, Riethmüller J, Wilker B, De Oliveira-Munding CC, van Heeckeren AM, Barr ML, von KG, Schmid KW, Weller M, Tümmler B, Lang F, Grassme H, Döring G, Gulbins E (2008) Ceramide accumulation mediates inflammation, cell death and infection susceptibility in cystic fibrosis. Nat Med 14:382-391.
47. Weidman SW, Beard JD, Sabesin SM (1984) Plasma lipoprotein changes during abstinence in chronic alcoholics. Atherosclerosis 52:151-166.
48. Wiesner P, Leidl K, Boettcher A, Schmitz G, Liebisch G (2009) Lipid profiling of FPLC-separated lipoprotein fractions by electrospray ionization tandem mass spectrometry. J Lipid Res 50:574-585.
49. Wong ML, Xie B, Beatini N, Phu P, Marathe S, Johns A, Gold PW, Hirsch E, Williams KJ, Licinio J, Tabas I (2000) Acute systemic inflammation up-regulates secretory sphingomyelinase in vivo: a possible link between inflammatory cytokines and atherogenesis. Proc Natl Acad Sci USA 97:8681-8686.
50. Yu ZF, Nikolova-Karakashian M, Zhou D, Cheng G, Schuchman EH, Mattson MP (2000) Pivotal role for acidic sphingomyelinase in cerebral ischemia-induced ceramide and cytokine production, and neuronal apoptosis. J Mol Neurosci 15:85-97.
51. Zeidan YH, Hannun YA (2007) Activation of acid sphingomyelinase by protein kinase Cδ-mediated phosphorylation. J Biol Chem 282:11549-11561.